PLANTATION, Fla. - StemSation International (OTC: STSN), a company specializing in the production and distribution of flavored, canned oxygen products, has completed the acquisition of Gorilla Marketing Group, LLC (GMG), the firm announced today. This strategic move is expected to enhance StemSation's presence in the THC-P vape and lifestyle product markets. The company's stock has shown remarkable momentum, with a 93.67% year-to-date return and a recent 13.33% gain over the past week, according to InvestingPro data.
GMG, known for its high-end AlienHouse vape product line, has become a part of StemSation following a previously announced Letter of Intent. As part of the acquisition, GMG's leadership will join StemSation's Board of Directors, and GMG shareholders will obtain approximately 35% of StemSation's common shares.
With a current market capitalization of $4.01 million and a "FAIR" financial health rating from InvestingPro, StemSation is positioning itself for growth. Benjamin Silber, CEO of StemSation, expressed confidence in the acquisition, stating that GMG is a growing company in a market with significant potential for mid and long-term growth. He emphasized the synergy between the two companies, with plans to improve efficiencies, finance product launches, and expand into broader retail markets.
Mike Gaya, CEO of GMG, also commented on the acquisition, noting the exciting growth prospects in the THC-P vape market and the strength of AlienHouse's marketing and branding, which he believes will bring value to StemSation stakeholders.
The acquisition aligns with industry trends, as convenience stores have experienced record sales, with $327.6 billion from in-store sales in 2023, according to the National Association of Convenience Stores (NACS). StemSation aims to leverage this trend, targeting the valuable retail space around store cashiers to boost sales through impulse purchases.
While the press release contains forward-looking statements, these should not be seen as guarantees of future performance or results for StemSation's common stock. Investors seeking deeper insights can access additional financial metrics and 7 exclusive ProTips through InvestingPro, including detailed analysis of the company's price momentum and profit margins. The company's filings with the OTC Markets can provide additional information on its plans and financial position.
This news is based on a press release statement from StemSation International, Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.